Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Exercise, Blood Pressure, Vasodilation, Vascular Function in Healthy Volunteers, Exercise Performance, Safety and Tolerability in Healthy Volunteers

In brief

Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance

Key facts

Study ID: NCT06894875
Run by: Nuritas Ltd
People needed: 48
Starts: 2025-06-24
Expected to finish: 2026-03-30
Last updated by the study team: 2025-12-16

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Willing to provide written and dated informed consent to participate in the study.
Willing and able to comply with the protocol.
Are not on any medication, or supplements which would impact the trial in the opinions of the investigator or Sponsor.
Male or female between 18 and 45 years of age (18.5 kg/m2 ≥ BMI < 30 kg/m2).
Comply with ACSM guidelines for physical activity.
Have not participated in a clinical trial within the past month and agree to not participate in another clinical trial during the study period.
Agree to not significantly alter diet or exercise routine during the trial period.
Willing to wear a wearable device continuously for the duration of the study

You may not qualify if…

Subjects having a known allergy or hypersensitivity to any of the ingredients in the investigational products.
Subjects with a history of alcohol and/or other drug abuse in the past year.
Has performed strenuous exercise (rating of perceived exertion ≥ 13) ≤ 48 hours before laboratory visit (Borg, 1982).
Consuming >14 alcoholic drinks per week or > 2 drinks/day in the 48 hours preceding a clinic visit.
Active smokers, nicotine use or vaping
Subjects suffering from a sleep disorder and/or who have a known history of (or was being treated for) clinical depression, eating disorder(s) or any other psychiatric condition(s) that might put the subject at risk and/or confounded the results of the study.
Subjects with a history of being diagnosed with phenylketonuria or another disease affecting amino acid metabolism (i.e., maple syrup urine disease, etc.).
Subjects with an elevated resting heart rate (>100 bpm) or blood pressure (systolic BP >140 mmHg or diastolic BP >90 mmHg).
Pregnant or lactating women
Presentation of orthostatic hypotension during the screening and familiarisation study visit
Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion.

Where it is running

Baker Heart and Diabetes Institute — Melbourne, Victoria, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.